GLP-1 (Glucagon-like Peptide-1) is a hormone naturally released in the gut in response to eating, but its therapeutic action is significantly enhanced by Semaglutide
This review synthesizes available evidence, explores mechanistic pathways, and provides guidance for clinicians counseling reproductive-aged patients receiving GLP-1 RAs
Sawicka A.K., Renzi G., Olek R.A
Insulin sensitivity improvements compound with the changes already driven by weight loss
Our experienced team also focuses on personalized dosing and treatment plans, tailoring each session to your individual wellness goals
Activating all three pathways at once signals your body to eat less, process glucose better, and burn fat faster